Skip to content
(212) 203-2813 115 East 57th Street Suite 1210, NY, NY 211 East 43rd Street, Ste 2300, NY, NY

OUR MISSION STATEMENT

The Center for Clinical Studies (CSS) is the official research division of the Ainsworth Institute and is committed to bringing the future of medicine to the forefront of today. By participating in research studies and clinical trials, our physicians are able to offer the most cutting edge treatments to our patients that are not yet available to the public at-large.

Who We Are

Our center conducts clinical trials and participates in the research and development of therapies and technologies that will allow the field of pain management to grow to be able to allow patients even better outcomes.

Our research department gives patients access to the most advanced technologies in existence and works to develop strategies in conjunction with industry experts to allow individuals the best care with the least risk.

What Sets Us Apart

Our center conducts clinical trials and participates in the research and development of therapies and technologies that will allow the field of pain management to grow to be able to allow patients even better outcomes.

Our research department gives patients access to the most advanced technologies in existence and works to develop strategies in conjunction with industry experts to allow individuals the best care with the least risk.

Clinical research, clinical trial, Pain NYC, stem cells

Blerona Shaipi, MD – Clinical Research Administrator for CCS

Current Clinical Trials & Research Studies

TISSUE GENE STUDY – Stem Cell Therapy for Chronic Knee Pain

The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of a type of stems cell called a “juvenile chondrocyte” for the treatment of chronic knee pain.
Chronic knee osteoarthritis (OA) is one of the most common diseases of advanced age with as many as 1 million sufferers in the United States alone. Typically, the only definitive treatments are injections – and if injections are unsuccessful, a knee replacement. Close to 700,000 people received knee replacements each year according to the CDC. This study will investigate the use of stem cells as a safe alternative to surgery.

ENROLLMENT CLOSED

TISSUE GENE STUDY – Stem Cell Therapy for Chronic Knee Pain
The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of a type of stems cell called a “juvenile chondrocyte” for the treatment of chronic knee pain. Chronic knee osteoarthritis (OA) is one of the most common diseases of advanced age with as many as 1 million sufferers in the United States alone. Typically, the only definitive treatments are injections – and if injections are unsuccessful, a knee replacement. Close to 700,000 people received knee replacements each year according to the CDC. This study will investigate the use of stem cells as a safe alternative to surgery.
ENROLLMENT – CLOSED

HOPE TRIAL – Closed Loop Stimulation for Chronic Pelvic Pain and Pudendal Neuralgia

The Ainsworth Institute is initiating a prospective clinical trial on the use of Closed Loop Stimulation to treat one of THE most painful and most difficult to treat pain syndromes known to man – Chronic Pelvic Pain (CPP).

Closed Loop Stimulation is technological breakthrough whereby a neurostimulator can interpret the electrical signals from the spinal cord the same way a cardiac pacemaker can with the heart – this advancement equated to superior results in the EVOKE clinical trial which the Ainsworth Institute was a part of.  Seeing the immense potential of this amazing therapy, Dr. Hunter pioneered the application of Closed Loop Stimulation on pelvic pain/pudendal neuralgia, thereby discovering the neural targets for treating this incredibly elusive syndrome.  The Ainsworth Institute will be heading up this first of a kind study that will hopefully generate promising data and prove the potential efficacy of this treatment.

ENROLLMENT OPEN

Pudendal Neuralgia, Pelvic Pain, Chronic Pelvic Pain, Pudendal Neuralgia Treatments

SEE IF YOU QUALIFY FOR THE STUDY

Pudendal Neuralgia, Pelvic Pain, Chronic Pelvic Pain, Pudendal Neuralgia Treatments

HOPE TRIAL Closed Loop Stimulation for Chronic Pelvic Pain and Pudendal Neuralgia

The Ainsworth Institute is initiating a prospective clinical trial on the use of Closed Loop Stimulation to treat one of THE most painful and most difficult to treat pain syndromes known to man – Chronic Pelvic Pain (CPP). Closed Loop Stimulation is technological breakthrough whereby a neurostimulator can interpret the electrical signals from the spinal cord the same way a cardiac pacemaker can with the heart – this advancement equated to superior results in the EVOKE clinical trial which the Ainsworth Institute was a part of.  Seeing the immense potential of this amazing therapy, Dr. Hunter pioneered the application of Closed Loop Stimulation on pelvic pain/pudendal neuralgia, thereby discovering the neural targets for treating this incredibly elusive syndrome.  The Ainsworth Institute will be heading up this first of a kind study that will hopefully generate promising data and prove the potential efficacy of this treatment.
ENROLLMENT – OPEN

Previous Studies

Seikagaku Study – Testing a One-Time Investigational Treatment for Lumbar Disc Herniation

The purpose of this study is to evaluate the effectiveness (how well the study drug works) and long-term safety of the study drug in people with leg pain due to a lumbar disc herniation.

The study drug might help the discomfort associated with lumbar disc herniation. Previous studies with the study drug showed a possible benefit in some patients. Your participation in this study may benefit the community, scientists, and doctors by providing increased knowledge and information about the treatment of lumbar disc herniation.

Sciatica Treatment, Pain Doctor New York, Pain Doctor NYC
Seikagaku Study

Seikagaku StudyTesting a One-Time Investigational Treatment for Lumbar Disc Herniation

The purpose of this study is to evaluate the effectiveness (how well the study drug works) and long-term safety of the study drug in people with leg pain due to a lumbar disc herniation.

The study drug might help the discomfort associated with lumbar disc herniation. Previous studies with the study drug showed a possible benefit in some patients. Your participation in this study may benefit the community, scientists, and doctors by providing increased knowledge and information about the treatment of lumbar disc herniation.

PRESS REGISTRY – Indirect Decompression of the Lumbar Spine Using an Interspinous Spacer to Treat Spinal Stenosis

The Ainsworth Institute has been selected to join a post-market study called the PRESS Registry which will examine the safety and LONG-TERM efficacy of the Superion™ Interspinous Spacer as a treatment for Lumbar Spinal Stenosis (LSS).  LSS is traditionally treated by a invasive procedure called a “laminectomy” which involves removing a large piece of bone on the spinal column to create more room for the spinal cord.  This procedure is very effective in many cases, however the chance of the procedure failing or causing the pain to get worse can be as high as 40%.  The recovery time for a laminectomy can be rough, it typcally requires an overnight stay in the hospital and it is irreversible.  The Superion™ Interspinous Spacer is an extremely effective alternative to a laminectomy and has shown efficacy out to 5-years.

Spinal Stenosis, Spinal Stenosis Treatment, LSS, LSS Treatment, Pain Doctor New York
Spinal Stenosis, Spinal Stenosis Treatment, LSS, LSS Treatment, Pain Doctor New York

PRESS REGISTRY Indirect Decompression of the Lumbar Spine Using an Interspinous Spacer to Treat Spinal Stenosis

The Ainsworth Institute has been selected to join a post-market study called the PRESS Registry which will examine the safety and LONG-TERM efficacy of the Superion™ Interspinous Spacer as a treatment for Lumbar Spinal Stenosis (LSS). LSS is traditionally treated by a invasive procedure called a “laminectomy” which involves removing a large piece of bone on the spinal column to create more room for the spinal cord. This procedure is very effective in many cases, however the chance of the procedure failing or causing the pain to get worse can be as high as 40%. The recovery time for a laminectomy can be rough, it typcally requires an overnight stay in the hospital and it is irreversible. The Superion™ Interspinous Spacer is an extremely effective alternative to a laminectomy and has shown efficacy out to 5-years.

TARGET Study – Dorsal Root Ganglion Stimulation for the Treatment of Complex Regional Pain Syndrome (CRPS)

Abbott is conducting a phase IV, post market study, clinical trial on the DRG stimulator. The FDA recently approved this amazing therapy on February 2016 for the treatment of Complex Regional Pain Syndrome (CRPS).

The phase III clinical trial, known as the ACCURATE study, showed that DRG stimulation was effective in 93.3% of patients with CRPS. The TARGET study is being conducted at a handful of sites around the United States – the Ainsworth Institute is the only site in New York State, or the tri-state area.

DRG Stimulation, CRPS treatment, complex regional pain syndrome treatment, RSD treatment, reflex sympathetic dystrophy treatment, clinical trial
DRG Stimulation, CRPS treatment, complex regional pain syndrome treatment, RSD treatment, reflex sympathetic dystrophy treatment, clinical trial

TARGET Study – Dorsal Root Ganglion Stimulation for the Treatment of Complex Regional Pain Syndrome (CRPS)
St. Jude Medical is conducting a phase IV, post market study, clinical trial on the DRG stimulator. The FDA recently approved this amazing therapy on February 2016 for the treatment of Complex Regional Pain Syndrome (CRPS).
The phase III clinical trial, known as the ACCURATE study, showed that DRG stimulation was effective in 93.3% of patients with CRPS. The TARGET study is being conducted at a handful of sites around the United States – the Ainsworth Institute is the only site in New York State, or the tri-state area.

BENEFIT-02 STUDY – A Brand New Spinal Cord Stimulation Technology for Treating Chronic Low Back and/or Leg Pain

Biotronik is conducting a phase I clinical trial on their stimulation system and its efficacy for treating low back and leg pain.

Spinal cord stimulation has been used to treat various types of chronic pain for decades.  While many have benefited from this therapy over time, there remains a great deal of room for improvement with regards to percentage of people who respond and the degree of relief one can achieve.  In this clinical trial, patients will complete a standard commercial stimulator trial – after which, they will be able to extend their trial experience for an additional 12-days using the experimental Biotronik system while awaiting their implant.

Saluda, EVOKE, clinical trial low back pain, clinical trial leg pain
Saluda, EVOKE, clinical trial low back pain, clinical trial leg pain

BENEFIT-02 STUDY – A Brand New Spinal Cord Stimulation Technology for Treating Chronic Low Back and/or Leg Pain
Biotronik is conducting a phase I clinical trial on their stimulation system and its efficacy for treating low back and leg pain. Spinal cord stimulation has been used to treat various types of chronic pain for decades. While many have benefited from this therapy over time, there remains a great deal of room for improvement with regards to percentage of people who respond and the degree of relief one can achieve. In this clinical trial, patients will complete a standard commercial stimulator trial – after which, they will be able to extend their trial experience for an additional 12-days using the experimental Biotronik system while awaiting their implant.

GRATIFY-1 STUDY – Genicular Radiofrequency Ablation (RFA) To Improve Post-Op Function & Recovery

In some cases, knee surgery is unavoidable – despite our best efforts. Our center is investigating the use of conventional RFA on the knee before surgery to see if patients have improved pain and recovery after surgery.

By using RFA on the genicular nerves outside the knee, our doctors can reduce pain inside the knee during the post-operative period – similar to the regional anesthesia given in the operating room just before the operation. The difference is this regional anesthesia will wear off in matter of hours, whereas RFA can last for months! With decreased pain after surgery, our doctors theorize patients will need less pain medication and make bigger strides in rehab and physical therapy leading to better function in a shorter period of time.

GRATIFY-1 Study – Radiofrequency Ablation (RFA) of the Knee before Surgery to Improve Post-Op Recovery
In some cases, knee surgery is unavoidable – despite our best efforts. Our center is investigating the use of conventional RFA on the knee before surgery to see if patients have improved pain and recovery after surgery.
By using RFA on the genicular nerves outside the knee, our doctors can reduce pain inside the knee during the post-operative period – similar to the regional anesthesia given in the operating room just before the operation. The difference is this regional anesthesia will wear off in matter of hours, whereas RFA can last for months! With decreased pain after surgery, our doctors theorize patients will need less pain medication and make bigger strides in rehab and physical therapy leading to better function in a shorter period of time.

MESOBLAST STUDY – Stem Cell Therapy for Chronic Discogenic Low Back Pain
The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of mesenchymal stem cells for the treatment of chronic low back back pain.
Low back pain affects 9 out of 10 Americans and is the 5th most common reason to go to the doctor. This trial will study the use of stem cells to potentially repair damaged spinal discs and decrease low back pain.  It is being conducted in several cities around the country; we are the only cite in the trip-state area!

MESOBLAST STUDY – Stem Cell Therapy for Chronic Discogenic Low Back Pain
The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of mesenchymal stem cells for the treatment of chronic low back back pain.
Low back pain affects 9 out of 10 Americans and is the 5th most common reason to go to the doctor. This trial will study the use of stem cells to potentially repair damaged spinal discs and decrease low back pain. It is being conducted in several cities around the country; we are the only cite in the trip-state area!

EVOKE STUDY – Closed Loop Stimulation for Chronic Low Back and/or Leg Pain
Our institute has been chosen to participate in the extremely prestigious EVOKE study – a phase 3 clinical trial on a device that can communicate with the spinal cord and adapt and pain patterns change.  We are 1 of just 11 sites selected to take part in this historic clinical trial. 
Spinal cord stimulation has been used to treat various types of chronic pain for decades.  While many have benefited from this therapy over time, there remains a great deal of room for improvement with regards to percentage of people who respond and the degree of relief one can achieve.  In this clinical trial, we will be studying a remarkable new stimulator technology that may very well change the face of medicine forever.

Saluda, EVOKE, clinical trial low back pain, clinical trial leg pain
Saluda, EVOKE, clinical trial low back pain, clinical trial leg pain

EVOKE STUDY – Closed Loop Stimulation for Chronic Low Back and/or Leg Pain
Our institute has been chosen to participate in the extremely prestigious EVOKE study – a phase 3 clinical trial on a device that can communicate with the spinal cord and adapt and pain patterns change. We are 1 of just 11 sites selected to take part in this historic clinical trial.
Spinal cord stimulation has been used to treat various types of chronic pain for decades. While many have benefited from this therapy over time, there remains a great deal of room for improvement with regards to percentage of people who respond and the degree of relief one can achieve. In this clinical trial, we will be studying a remarkable new stimulator technology that may very well change the face of medicine forever.

VAST STUDY – Stem Cell Therapy for Chronic Discogenic Low Back Pain
The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of mesenchymal stems cells with a nucleus fibrosis scaffolding for the treatment of chronic low back back pain.

Low back pain affects 9 out of 10 Americans and is the 5th most common reason to go to the doctor. This trial will study the use of stem cells to potentially repair damaged spinal discs and decrease low back pain.  It is being conducted in several cities around the country; we are the only cite in the trip-state area!

VAST STUDY – Stem Cell Therapy for Chronic Discogenic Low Back Pain
The Ainsworth Institute of Pain Management has been selected to join a phase 3 clinical trial studying the safety and efficacy of mesenchymal stems cells with a nucleus fibrosis scaffolding for the treatment of chronic low back back pain.
Low back pain affects 9 out of 10 Americans and is the 5th most common reason to go to the doctor. This trial will study the use of stem cells to potentially repair damaged spinal discs and decrease low back pain. It is being conducted in several cities around the country; we are the only cite in the trip-state area!

KNEE PAIN STUDY – Coolief™ Cooled Radiofrequency Ablation to Treat Chronic Knee Pain
The Ainsworth Institute is investigating the use of Cooled Radiofrequency Ablation to treat chronic knee pain. Our center is one of just 12 sites throughout the country (the only center in the tri-state area) who has been asked to participate in this groundbreaking study.

Chronic knee osteoarthritis (OA) is one of the most common diseases of advanced age with as many as 1 million sufferers in the United States alone. Typically, the only definitive treatments are injections – and if injections are unsuccessful, a knee replacement. Close to 700,000 people received knee replacements each year according to the CDC. This study will investigate the use of Cooled Radiofrequency as a safe alternative to surgery.

KNEE PAIN STUDY – Coolief™ Cooled Radiofrequency Ablation to Treat Chronic Knee Pain
The Ainsworth Institute is investigating the use of Cooled Radiofrequency Ablation to treat chronic knee pain. Our center is one of just 12 sites throughout the country (the only center in the tri-state area) who has been asked to participate in this groundbreaking study.
Chronic knee osteoarthritis (OA) is one of the most common diseases of advanced age with as many as 1 million sufferers in the United States alone. Typically, the only definitive treatments are injections – and if injections are unsuccessful, a knee replacement. Close to 700,000 people received knee replacements each year according to the CDC. This study will investigate the use of Cooled Radiofrequency as a safe alternative to surgery.

PHANTOM LIMB PAIN – Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System
The Ainsworth Institute of Pain Management has been selected to join an ongoing clinical trial that will investigate the use of Neuromodulation for the treatment of Phantom Limb Pain. This new technology will study the effect of an electrode placed percutaneously on the sciatic or femoral nerve to treat this painful syndrome in amputees. 

The device is the first of its kind and will be placed under ultrasound guidance.  Unlike most nerve stimulators, there is no battery implanted – rather the battery is worn outside the body, on the skin.  Another unique aspect of this device is that it is meant to be temporary: this means patients will have the leads placed only for a few weeks and then removed.

PHANTOM LIMB PAIN – Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System
The Ainsworth Institute of Pain Management has been selected to join an ongoing clinical trial that will investigate the use of Neuromodulation for the treatment of Phantom Limb Pain. This new technology will study the effect of an electrode placed percutaneously on the sciatic or femoral nerve to treat this painful syndrome in amputees. The device is the first of its kind and will be placed under ultrasound guidance. Unlike most nerve stimulators, there is no battery implanted – rather the battery is worn outside the body, on the skin. Another unique aspect of this device is that it is meant to be temporary: this means patients will have the leads placed only for a few weeks and then removed.

CREATE-1 STUDY – CRPS Treatment Evaluation 2 Study
The Ainsworth Institute has been selected to join a worldwide clinical trial studying the efficacy and safety of the medication AXS-02 for the treatment of Complex Regional Pain Syndrome Type 1 (CRPS-1).

CRPS (aka RSD) is painful and debilitating condition affecting both men and women. What causes CRPS is a mystery and without treatment, it can progress to the point where a simple gust of wind can bring a person to their knees from pain. This study is phase 3 clinical trial evaluating an oral medication as a potential treatment for CRPS.

CRPS Complex Regional Pain Syndrome Clinical Trial
CRPS Complex Regional Pain Syndrome Clinical Trial

CREATE-1 STUDY – CRPS Treatment Evaluation 2 Study
The Ainsworth Institute has been selected to join a worldwide clinical trial studying the efficacy and safety of the medication AXS-02 for the treatment of Complex Regional Pain Syndrome Type 1 (CRPS-1).
CRPS (aka RSD) is painful and debilitating condition affecting both men and women. What causes CRPS is a mystery and without treatment, it can progress to the point where a simple gust of wind can bring a person to their knees from pain. This study is phase 3 clinical trial evaluating an oral medication as a potential treatment for CRPS.

PHANTOM LIMB PAIN – High Frequency Nerve Block for Post-Amputation Pain: A Pivotal Study
The Ainsworth Institute of Pain Management has been selected to join an ongoing clinical trial that will investigate the use of Neuromodulation for the treatment of Phantom Limb Pain. This new technology will study the effect of a new type of electrode placed on the sciatic nerve combined with a new type of waveform not currently used to treat this painful syndrome in amputees. 

Our Center for Clinical Studies has partnered with the Department of Neurosurgery at Mount Sinai Hospital here in Manhattan to perform this amazing study.  The study itself will be conducted out of our flagship office in Manhattan.

Saluda, EVOKE, clinical trial low back pain, clinical trial leg pain

Publications

Our physicians have been publishing in textbooks and peer-reviewed journals as well as lecturing around the country to share the results of our findings. These publications have been cited by additional researchers in their own studies as well as used by other pain management doctors to treat their own patients – thus aiding in the advancement of medicine and betterment of the field.

“An Analysis of the Concentration Yields of Commercially Available Platelet Rich Plasma Platforms.” Fadadu P, Hunter C, Davis T. Regional Anesthesia and Pain Medicine. Accepted – Pending Publication

“Neurostimulation for the Treatment of Chronic Head and Facial Pain: A Literature Review.” Antony A, Mazzola A, Hunter C. Pain Physician 2019; 22:447-477

“Chronic Pelvic Pain as a Form of Complex Regional Pain Syndrome.” Michael A, Hunter C. Practical Pain Management. 2019 19(6), 50-2.

“Cooled Radiofrequency Ablation Treatment of Osteoarthritis Knee Pain: 24-Month Results.” Hunter C, Davis T, Loudermilk E, et al. Pain Pract 2020 Mar;20(3):238-246.

“The MIST Guidelines: The Lumbar Spinal Stenosis Consensus Group for Minimally Invasive Spine Treatment.” Deer T, et al. Pain Pract. 2018 Oct 27. doi: 10.1111/papr.12744.

“Neuromodulation of the Dorsal Root Ganglion for Chronic Post-surgical Pain.” Antony A, Schultheis C, Jolly S, Bates D, Hunter C. Pain – Pain Med 2019 Jun 1;20(Suppl 1):S41-S46

“Burst Spinal Cord Stimulation: A Clinical Review.” Kirketeig T, Schultheis C, Zuidema X, Hunter, C. Pain Medicine – Pain Med 2019 Jun 1;20(Suppl 1):S31-S40.

“Safety Analysis of Dorsal Root Ganglion Stimulation in the Treatment of Chronic Pain.” Deer T, Pope J, Hunter C, et al. Neuromodulation. 2020 Feb;23(2):239-244.

“Percutaneous 60-day Peripheral Nerve Stimulation Implant Provides Sustained Relief of Chronic Pain Following Amputation: 12-month Follow-Up of a Randomized, Double-Blind, Placebo-Controlled Trial.” Gilmore C, Ilfeld B, Rosenow J, Li S, Hunter C, et al. Reg Anesth Pain Med. 2020 45(1), 44-51.

“Anatomy, Pathophysiology and Interventional Therapies for Chronic Pelvic Pain: A Review.” Hunter C, Stovall B, Chen G, Carlson J, Levy R.; Pain Physician. 2018; 21:147-167

“Spinal Cord Stimulation for the Treatment of Failed Neck Surgery Syndrome: Outcome of a Prospective Case Series.” Hunter C, Sayed D, Carlson J, Yang, A, Deer T.; Neuromodulation. 2018 Jul;21(5):495-503. doi: 10.1111/ner.12769.

“The Neuromodulation Appropriateness Consensus Committee (NACC) on Best Practices for Dorsal Root Ganglion Stimulation.” Deer T, et al.; Neuromodulation. 2018 Sep 24. doi: 10.1111/ner.12845.

“DRG FOCUS – A Multicenter Study Evaluating Dorsal Root Ganglion Stimulation and Predictors for Trial Success.” Hunter C, Sayed D, Lubenow T, Davis T, et al.; Neuromodulation. 2018 Aug 7. doi: 10.1111/ner.12796.

“Dorsal Root Ganglion Stimulation for Chronic Pelvic Pain: A Case Series and Technical Report on a Novel Lead Configuration.” Hunter C, Yang A.; Neuromodulation. 2018 Aug 1. doi: 10.1111/ner.12801

“Dorsal Root Ganglion Stimulation as a Salvage Treatment for Complex Regional Pain Syndrome Refractory to Dorsal Column Spinal Cord Stimulation: A Case Series,” Yang A, Hunter C.; Neuromodulation – Technology at the Neural Interface 2017; 20(7): 703-7.

“Selective Radiofrequency Ablation of the Dorsal Root Ganglion (DRG) as a Method for Predicting Targets for Neuromodulation in Patients With Post Amputation Pain: A Case Series,” Hunter C, Yang A, Davis T.; Neuromodulation Technology at the Neural Interface 2017; 20(7): 708-18.

“Neuromodulation of Pelvic Visceral Pain: Review of the Literature and Case Series of Potential Novel Targets for Treatment,” C. Hunter, N. Dave’, S. Diwan, T. Deer; Pain Practice. 13(1):3-17, 2013 Jan.

“A New Muscle Pain Detection Device to Diagnose Muscles as a Source of Back and/or Neck Pain,” C. Hunter, M. Dubois, S. Zou, W. Oswald, K. Coakley, M. Shebar, and A. M. Conlon; Pain Medicine. 11(1):35-43, 2010 Jan.

“Minimally Invasive Delivery of Stem Cells for Spinal Cord Injury: Advantages of the Lumbar Puncture Technique,” A. Bakshi, C. Hunter, S. Swanger, A. Lepore, and I. Fischer; Journal of Neurosurgery: Spine. 1(3):330-7, 2004 Oct.

Center for Clinical Studies

The Ainsworth Institute prides itself on having strong relationships with Industry & Medical Device Companies such as Abbott, Vertiflex, Saluda, TissueGene & Flowonix.  These relationships allow our doctors to stay on the cutting edge and help drive innovation in the field of pain management. Most importantly, it gives our Institute access to treatments not yet available to the general public within the United States.

Corey Hunter, M.D.